Ross Douthat interviews Dr. Jay Bhattacharya, the new NIH Director under the Trump administration, exploring how COVID-era controversies transformed him from Stanford professor to public health reformer. Bhattacharya co-authored The Great Barrington Declaration in October 2020, advocating for focused protection strategies that became a lightning rod in pandemic policy debates.

The conversation examines the collapse of public trust in medical institutions, with Bhattacharya arguing that authorities' refusal to acknowledge uncertainty and suppress dissenting voices during COVID created lasting damage. He faced professional attacks for early antibody studies showing the virus had spread more widely than recognized, challenging official mortality estimates and lockdown justifications.

As NIH Director, Bhattacharya aims to rebuild scientific credibility through three major reforms: addressing the replication crisis, refocusing research on health outcomes rather than political priorities, and demonstrating epistemic humility. The discussion covers controversial topics including vaccine policy, chronic disease research, and the administration's approach to restoring public trust in science.

The COVID-Era Break: From Academic to Controversialist

Bhattacharya describes his pre-pandemic naivety: "I thought public health had the best interests of the working class, the poor in mind. The COVID era shattered my illusions on all of those fronts."

His March 2020 Wall Street Journal op-ed used Diamond Princess data to show COVID's age-stratified risk profile was already clear by January 2020, contradicting broad lockdown approaches.

Early antibody studies in April 2020 found 3% population infection rates, meaning "for every infected person who was a case that had been identified, there were 50 people walking around with antibodies."

Instead of scientific debate, Bhattacharya faced "attacks on my character, an attempt to destroy my career, questions about the integrity of my work that were completely spurious."

Lab Leak Theory and the Suppression of Scientific Debate

Bhattacharya believes COVID-19 originated from a lab accident with "pretty close to certain" confidence, though acknowledges "excellent scientists that don't think it was lab leak."

Gain-of-function research from 2003-2020 involved manipulating wild viruses to make them "potentially more dangerous and more infectious to humans" to identify pandemic threats and develop countermeasures.

The lab leak possibility created institutional incentives to suppress debate: "If you're responsible for unleashing hell on the world, what would you do? You're going to try to shut it down with whatever means."

Public health authorities couldn't tolerate dissent because "if there's debate, it's not going to happen. You're not going to have another lockdown" without unified messaging.

Lockdown Effectiveness and the Great Barrington Declaration

The Great Barrington Declaration proposed focused protection strategies, but "we didn't try it at all sufficiently" with critics claiming "we were already doing this" while sending COVID patients to nursing homes.

Bhattacharya argues lockdowns "ended up killing more people than would have been killed had those lockdowns not happened" through missed medical care and economic disruption.

The fundamental error was assuming extraordinary measures would work without evidence: "You take away basic civil liberties at scale for nine months... That I think is the end of civilization."

Simple protective measures were ignored, like preventing nursing home staff from working at multiple facilities, which research showed spread disease between institutions.

Rebuilding Trust Through Scientific Reform

Current public trust in science at 75% is insufficient: "It's not politics where if I get 50 plus one, I've succeeded. If I'm at 75% of our scientific work, that's too low a bar. It needs to be 100."

The replication crisis affects "large chunks of the scientific literature" across neurosciences, cancer biology, and psychology, making drug development unreliable and wasteful.

Bhattacharya proposes a "second scientific revolution" where replication work becomes honored rather than unsexy, democratizing "who gets to decide what's true and false in science."

NIH will crowdsource replication priorities, create journals for negative results, and develop metrics rewarding scientists who welcome replication of their work.

NIH Reform Agenda: Cost, Innovation, and Health Outcomes

Despite medical advances like sickle cell anemia cures, "life expectancy has been flat" since 2010, with 2024 levels only returning to 2019 baselines.

Cost barriers prevent breakthrough adoption: sickle cell treatment costs $3 million, but "if it costs $30,000, there would be no more sickle cell anemia in the United States."

Drug repurposing research is underfunded, citing a Stanford colleague's difficulty getting resources to test old shingles vaccine for dementia prevention in large trials.

Scientific directors now have freedom to fund innovative ideas with high failure rates: "I'm going to view that as a successful portfolio" rather than only funding likely-to-succeed projects.

Vaccine Policy and Restoring Confidence

Measles vaccine uptake at 92% is "too low" for herd immunity, with declining trust across rural counties and immigrant communities affecting both red and blue states.

The administration distinguishes vaccines "common all through the rest of the world" from US-specific recommendations, using Danish vaccine schedules as trusted international standards.

Bhattacharya clearly recommends MMR, polio, and DPT vaccines for children but questions COVID vaccines for six-month-olds, showing "room for nuance" and "humility."

The approach emphasizes engagement over suppression: "We are allowing a wider range of public debate over these issues than public health in the United States is traditionally comfortable with."

Chronic Disease Research and Scientific Humility

Many chronic conditions like chronic fatigue syndrome are "labels that describe symptoms" without understanding origins or treatments, leaving patients feeling dismissed as psychological cases.

Bhattacharya launched an autism data science initiative explicitly stating "I don't know what the answer is" and requesting "a wide range of hypotheses to be tested."

Research approaches must be heterogeneous because chronic diseases are varied, with some patients responding to treatments that fail for others with similar diagnoses.

Scientific method applied with epistemic humility can advance understanding: "I don't think you're crazy just because you say you have a condition that I don't understand."